Literature DB >> 16702907

The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.

Gabriel Rubio, Miguel A Jiménez-Arriero, Isabel Martínez-Gras, Jorge Manzanares, Tomás Palomo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16702907     DOI： 10.1097/01.jcp.0000220524.44905.9f

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  14 in total

1.  Anxiety and Substance Use Disorders: A Review.

Authors:  Joshua P Smith; Sarah W Book
Journal:  Psychiatr Times       Date:  2008-10

2.  Topiramate augmentation in a patient with obsessive-compulsive disorder.

Authors:  Michael Van Ameringen; Beth Patterson
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

Review 3.  Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.

Authors:  Leonardo F Fontenelle; Sanne Oostermeijer; Ben J Harrison; Christos Pantelis; Murat Yücel
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 4.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 6.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

7.  THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER.

Authors:  Frank P MacMaster; David R Rosenberg
Journal:  Child Adolesc Psychopharmacol News       Date:  2010-12

Review 8.  Translational neuroimaging research in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

10.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.